Global Cell Culture Media, Sera, and Reagents Market – Overview

In recent years, there has been a growing prevalence of chronic diseases across the globe. This has prompted an increased demand for the treatment of the same and also some new and innovative ways of treatment. This demand has been the chief driving factor for the overall development of the global cell culture media, sera, and reagents market. With this growing demand and emerging trends, there have been growing investments and funding to fuel the activities of research and development of the new products. Such developments in the pharmaceutical sectors coupled with increasing application of the cell culture have also helped in the overall development of the global market.

The report published by Transparency Market Research expects the global cell culture media, sera, and reagents market to touch the mark of US$11.3 bn by the fall of year 2022. Initially, in 2013, the valuation of the global cell culture media, sera, and reagents market was US$6 bn. For the given period of forecast, the global cell culture media, sera, and reagents market is expected to exhibit a promising CAGR of 7.1%. The growing demand for bio-pharmaceuticals is also expected to work in favor of the market development as it will provide highly specific solutions while taking into consideration the existing genetic markup of the patient. Moreover, it will also consider the biological as well as the psychological needs of the patient. The increasing demand for as well the rising adoption of synthetic orangs is also expected to benefit the growth of the global cell culture media, sera, and reagents market in the coming years of the forecast period.

The global cell culture media, sera, and reagents market is segmented in terms of type of media, type of sera, type of reagents, and region. In terms of type of media, the market is further segmented into chemically defined, classical, lysogeny broth (LB), protein free, serum free, and specialty media among others.

On the other hand, in terms of type of sera, the global cell culture media, sera, and reagents market is further segmented into adult bovine, newborn calf, and fetal bovine. In terms of type of reagents, the global market is further segmented into Hormones, growth factors and cytokines, attachment factors, amino acids, and albumin.

Early Access to New Technology to Push North America Region’s Growth

In terms of regional segmentation, there are five key regions of the global cell culture media, sera, and reagents market. These regions are North America, Latin America, Asia Pacific, Middle East and Africa, and Europe. Of these regional segments, the region of North America has been identified as the most dominant one. The regional segment was valued at US$2.2 bn in the year 2014. With a promising rate of growth, the regional segment of North America of the cell culture media, sera, and reagents market is expected to reach a valuation worth US$3.7 bn by the fall of 2022. High incidence of cancer, growing prevalence of chronic diseases, and others are some of the key factors behind the development of the regional segment. Moreover, introduction as well as early access to latest technology such as automated cell instruments and 3D cell culture are also expected to help the growth of the regional market.

Product Innovation Is Key for Leading Market Players

The research report expects the segment of cell culture media to hold the leading share in the global market. Segment is expected to exhibit an impressive CAGR 8.8% for the forecast period of 2014 to 2022. The constant efforts to offer high-end and high quality media for getting reliable, reproducible, and accurate results are projected to be the key reasons behind the dominance of the segment.

Some of the key players operating in the global cell culture media, sera, and reagents market include names such as GE Healthcare, Sigma-Aldrich Corporation, BD Biosciences, VWR International, EMD Millipore, Lonza Biosciences, and Thermo Fisher Scientific, Inc. These leading players are concentrating on product development and innovation for staying relevant and ahead of the market competition.

The global cell culture media, sera, and reagents market is forecasted to be driven by the irresponsiveness of treatment of various illnesses through traditional methods of treatment. The dwindling difference between a pharmaceutical and a biotechnology company are likely to fuel the emergence of biotech firms in the market, These companies are fast coming up with specialized methods of treatment through personalized medications by emphasizing on stem cell research.

In addition to that, low competition from the end of bio-similar or generic drugs is likely to exert positive influence on the global cell culture media, sera, and reagents market. Such growth of the market is likely to be driven by the inability of the manufacturers of bio-similar drugs to recreate a unique processing technique of microorganisms in a highly regulated environmental scenario.

Emergence of Bio-technology Firms to Bolster Demand in the Market

In the last few years, there has been rising incidences of chronic diseases all over the world. This has led to an augmented demand for the treatment of chronic diseases. High prevalence of chronic diseases has also generated demand for innovative new methods of treatment. This demand for novel methods of treatment is likely to play a significant role in the expansion of the global cell culture media, sera, and reagents market in near future. 

With this emerging trends and increasing demand, there has been rising investments and funding to fuel research and development activities for the invention of new products. The global cell culture media, sera, and reagents market is expected to be influenced by the augmented application of cell culture in the treatment of various diseases.

In terms of type of media, the global cell culture media, sera, and reagents market is further categorized into the following

  • chemically defined
  • protein free
  • classical
  • serum free
  • lysogeny broth (LB)
  • specialty media

In addition, the rising demand for bio-pharmaceuticals is also expected to  support new developments. It is expected to offer extremely specific solutions whilst taking existing generic markup of the patient into consideration.

The global cell culture media, sera and reagents market is witnessing impressive growth due to the increase in demand for biopharmaceutical products. Since its introduction as an integral part of the life sciences industry, the cell culture market has witnessed significant growth in terms of scope as well as adoption by the end-users. The double-digit growth in the biotechnology and biopharmaceutical industries is the major factor likely to boost the growth of the cell culture media, sera and reagents market in the near future.

The market has been extensively analyzed on the basis of media, sera, reagents, and geography. Cell culture media are further segmented into chemically defines media, classical media, lysogeny broth, protein-free, serum-free and specialty media; segment for cell culture sera is sub-segmented into fetal bovine serum, newborn calf and adult bovine serum and others; and reagents segmented to further divided into albumin, amino acids, attachment factors, growth factors and cytokines, protease inhibitors, and others. Albumin market is further studied for human serum albumin, bovine serum albumin, and recombinant serum albumin. Growth factors and cytokines market is studied for insulin-like growth factors, interleukins and interferons, tumor necrosis factors and other growth factors and cytokines. The others reagents segment is further divided in porcine trypsin, recombinant trypsin, thrombin and miscellaneous reagents.  

Each of the segments has been analyzed in detail for market trends, recent developments, outlook, and opportunities. The report provides current and future market size for each segment and sub-segment for the period from 2013 to 2023, in terms of revenue in USD million considering 2013 and 2014 as the base years. The compound annual growth rate (% CAGR) for each market segment has been provided for the forecast period from 2015 to 2023 along with the estimations of market size.

Geographically, the global cell culture media, sera and reagents market has been classified into five major regions: North America (the U.S., Canada), Europe (Germany, the U.K., Rest of Europe), Asia Pacific (Japan, China, India, Korea, Rest of Asia Pacific), Latin America (Brazil, Mexico, Rest of Latin America), and Rest of the World (RoW) (Israel and Russia). The regions have been further segmented by media, sera and reagents. The current and future market sizes in terms of revenue (USD million) of these regional markets and their major countries have been provided in the report for the period from 2013 to 2023, with their growth rate (%) for the period from 2015 to 2023. The study also offers a list of recommendations and highlights of the market for new companies willing to enter the market and for existing companies to increase market shares, which is likely to help in the decision-making process. 

The market overview section of the report demonstrates the market dynamics and market trends such as drivers, restraints, and opportunities that influence the current and future status of the cell culture industry. The report also covers market attractiveness analysis, Porter’s Five Forces Analysis and key market share analysis in the market overview section, in order to give a thorough analysis of the overall competitive scenario in the global cell culture media, sera and reagents market. 

The competitive landscape section of the report includes the market share analysis of major players in the cell culture media, sera and reagents market for the year 2013. The report concludes with the company profiles section that includes key information about the major players in the market. Key players profiled in this report include BD Biosciences, Corning Incorporated, EMD Millipore, GE Healthcare, Lonza Group, Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., VWR International, LLC, and PromoCell GmbH. Each of these players is profiled in the report considering parameters such as company overview, financial overview, business strategies, product portfolio, and recent developments.

The global cell culture media, sera, and reagents market has been segmented as given below:

Global Cell Culture Media Market Revenue, by Type

  • Chemically defined
  • Classical
  • Lysogeny broth (LB)
  • Protein-free
  • Serum-free
  • Specialty

Global Cell Culture Sera Market Revenue, by Type

  • Fetal Bovine
  • Newborn Calf and Adult Bovine Sera
  • Others

Global Cell Culture Reagents Market Revenue, by Type

  • Albumin
    • Human Serum Albumin (HSA)
    • Bovine Serum Albumin (BSA)
    • Recombinant Serum Albumin (RSA)
  • Amino Acids
  • Attachment Factors
  • Growth Factors & Cytokines
    • Insulin-like Growth Factors (IGF)
    • HumanKine Growth Factors and Cytokine
    • Tumor Necrosis Factor (TNF)
    • Others
  • Hormones (Insulin, Recombinant Insulin, Erythropoietin and Others)
  • Others
    • Porcine Trypsin
    • Recombinant Trypsin
    • Thrombin
    • Miscellaneous Reagents

Global Cell Culture Media, Sera, and Reagents Market Revenue, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Korea
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Rest of the World (RoW)
    • Israel
    • Russia
    • Rest of RoW

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Cell Culture Media Sera Reagents Market

Buy Now